Table 1 Logistic Regression for Transplant Utilization and Mortality.
From: Multiple myeloma incidence, transplant utilization, and mortality- impact of social vulnerability
Characteristic | ORa | 95% CIa | p-value | ORa | 95% CIa | p-value |
|---|---|---|---|---|---|---|
Transplant Utilization | Mortality | |||||
SVI – Continuous (No Race Theme) | 0.75 | 0.58, 0.99 | 0.041 | 1.49 | 1.16, 1.92 | 0.002 |
Age at Diagnosis - Continuous | 0.90 | 0.90, 0.91 | <0.001 | 1.07 | 1.07, 1.08 | <0.001 |
Sex | 0.7 | 0.067 | ||||
Female | — | — | — | — | ||
Male | 0.97 | 0.84, 1.12 | 0.7 | 1.14 | 0.99, 1.31 | 0.067 |
Race/Ethnicity | <0.001 | 0.7 | ||||
NH White | — | — | — | — | ||
NH Black/African American | 0.47 | 0.35, 0.62 | <0.001 | 1.04 | 0.81, 1.34 | 0.73 |
Hispanic | 0.35 | 0.19, 0.62 | <0.001 | 0.77 | 0.47, 1.26 | 0.29 |
NH Other/Unknown | 0.41 | 0.22, 0.71 | 0.0023 | 0.99 | 0.62, 1.60 | 0.96 |
Year of Diagnosis | <0.001 | <0.001 | ||||
2009 | — | — | — | — | ||
2010 | 0.89 | 0.59, 1.33 | 0.57 | 1.25 | 0.83, 1.90 | 0.28 |
2011 | 0.89 | 0.60, 1.32 | 0.56 | 0.62 | 0.43, 0.89 | 0.01 |
2012 | 1.44 | 0.99, 2.10 | 0.059 | 0.57 | 0.40, 0.83 | 0.0029 |
2013 | 1.16 | 0.80, 1.70 | 0.43 | 0.48 | 0.34, 0.68 | <0.001 |
2014 | 1.34 | 0.93, 1.95 | 0.12 | 0.35 | 0.25, 0.50 | <0.001 |
2015 | 1.97 | 1.38, 2.83 | <0.001 | 0.29 | 0.14, 0.29 | <0.001 |
2016 | 2.03 | 1.41, 2.92 | <0.001 | 0.21 | 0.14, 0.29 | <0.001 |
2017 | 2.16 | 1.50, 3.11 | <0.001 | 0.18 | 0.13, 0.25 | <0.001 |
2018 | 2.21 | 1.55, 3.17 | <0.001 | 0.10 | 0.07, 0.14 | <0.001 |
2019 | 2.29 | 1.62, 3.25 | <0.001 | 0.06 | 0.04, 0.09 | <0.001 |
Transplant Utilization | — | <0.001 | ||||
No | — | — | — | — | ||
Yes | — | — | — | 0.41 | 0.34, 0.48 | <0.001 |
